The intersection of JQ1 and GSK2801 putative BC targets gave some clues to the possible synergistic action of these two drugs by revealing CTSB, MAPK14, MET, PSEN2 and STAT3 genes as common BC targets. This evidence concerns the gene PSEN2 and breast cancer.